Changes in diagnosis, risk assessment, monitoring, and therapeutic management of AML with at least 12 approved therapies. 👍🏻 onlinelibrary.wiley.com/doi/10.1002/aj…

With Katerina Rohlenova pleased to announce the 2026 Prague Metabolism and Signaling Meeting (June 24-27). Two Keynotes (Vousden & Hall) and 30+ speakers in metabolism, mitochondria, aging, mTOR, & more. Please RT. Info, registration, & student discounts at: praguemetabolismsymposium.com

Another very special evening Bassaleg School being entertained by our fabulously talented young people! Thank you and huge congratulations to everyone involved and to all those who contribute to making brilliant music Bassaleg School #summerconcert 🎵

Week 2 at the MRC WIMM Completely clueless, imposter syndrome on 🔝level…BUT meeting with some of the researchers and finding out about their studies/interests….WOW!! My wee mind is blown! So super interesting! Excited to find out more 😄 Beth Psaila Adam Mead

(3/4) Research into new ex vivo model systems to study drug responses in haematopoiesis published in Experimental Haematology: exphem.org/article/S0301-… ISEH

5days until our London mini RNA symposium at Barts Cancer Institute (Queen Mary) on 16th July. We have put together excellent programme incl. talks by Kostas Tzelepis Magdalena Crossley Vikram Paralkar Hannah Lawson and early-career researchers. See you all next week . Programme 👇 thanks The RNA Society for support

Exciting and upportive opportunities below YoungEHA European Hematology Association 👇

Attending Graduation with Mandy Tonks to celebrate the successes of all our students in Cardiff University School of Medicine and this graduating with a PhD from Dept of Haematology, Cardiff University and Division of Cancer & Genetics

Check out our new preprint on an epigenetic resistance mechanism to PI3 kinase inhibition in AML and a new combination therapy with an EZH1/2 inhibitor that depletes leukemic stem cells! Great effort by Shira G-S, PhD and the whole team

exciting opportunity to come work with us on paediatric leukaemia for 9 months Research Technician - jobs.gla.ac.uk/job/research-t…

ASH Seeks Fundamental Discovery Science Abstracts for #ASH25 IF the quality is there, the fundamental basic science poster and presentations will E X P A N D at ASH25. Its an experiment! Submit your cool basic science before August 5, 2025, at 11:59 p.m.

Nearing the end/completed your PhD? Interested in leukaemia research? Want to join a new and exciting PI as they establish their group at Sussex Life Sciences Then this 3y post doc post with newly minted MRC CDA Fellow & Blood Cancer UK Research funded Dr Jasmeen Oberoi could be for you 👇

Come join a blossoming blood cancer research network here at University of Sussex which has just added its 10th group leader. Awesome opportunity to work alongside Dr Jasmeen Oberoi who will be a great mentor. All in a very supportive research institute and a beautiful region of the UK.

We’ve just held our 2025 Research Symposium, where we launched our bold new research strategy and committed £70m to blood cancer research over the next 5 years. Here are the top takeaways 👇 bit.ly/46bcayQ

It was wonderful to supervise Rosie over the last year in Division of Cancer & Genetics Dept of Haematology, Cardiff University with our collaborator J khorashad. Rosie will be missed 😭. Good luck for your final year and come back for a PhD! #AML #beatingbloodcancer #Tron #inception

Wishing Rosie Spiers a fond farewell and the best of luck for the future. Rosie will be returning to Biomedical Sciences at Cardiff to start her PhD studies following a year spent in Alex Tonks Lab. #AML#beatingbloodcancer [email protected]; Alex Tonks Division of Cancer & Genetics

Wishing Adam Golaup a fond farewell and the best of luck for the future. Adam will be returning to the Uni of West England to start his PhD studies following a year spent in Alex Tonks Lab. #AML#beatingbloodcancer [email protected];Alex Tonks; Division of Cancer & Genetics;UWE Bristol

A short thread about our new paper just published in Molecular Therapy Oncology. Terrific work from first author Dr Rebecca Bayliss 👏👏

Congrats to our researcher Dr Kez Cleal! 👏